HIQA launches public consultation on PrEP programme to prevent HIV

HIQA has launched a public consultation on a draft health technology assessment (HTA) of a pre-exposure prophylaxis (PrEP) programme for people at substantial risk of HIV.

PrEP is the most recent development in the field of HIV prevention, involving the pre-emptive use of oral antiretroviral therapy in HIV negative people to prevent infection.